Skip to content

Reflexology impact on reducing vomiting in patients undergoing chemotherapy

Reflexology impact on reducing vomiting in patients undergoing chemotherapy Oncology - Hematology Hospital Ali Ibn Abi Talib (AS) University in 1388

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903163417N2
Enrollment
35
Registered
2012-08-27
Start date
2009-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vomiting caused by chemotherapy. Nausea and vomiting

Interventions

Intervention 1: Control group in this study received anti-vomiting and Granisetron efficacious half-life 12-9 hours, which coincided with the start of chemotherapy were administered 3 mg and the docto
in case of hospitalized patients and vomiting in the drug Granisetron was used and the patient was in attendance and was controlled by telephone from IV metoclopramide was used). Intervention for this
Treatment - Drugs
Prevention
Control group in this study received anti-vomiting and Granisetron efficacious half-life 12-9 hours, which coincided with the start of chemotherapy were administered 3 mg and the doctor ordered.Granis
Samples in the next month (with a distance of 15 to 20 days before the visit) were in the intervention group. Before, the patient explained that in addition to all therapeutic measures that will be do

Sponsors

Research Assistance Shahid Beheshti Nursing and Midwifery University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: .1 - be alert. (Awareness of time and place and person) 2 - have over 18 years of age 3 - spent at least one course of chemotherapy and chemotherapy with drugs or treatment of moderate to severe can cause vomiting.4 - Side effects of acute vomiting that has occurred. 5 - other treatments such as radiation therapy during the study, it is not in the program. 6 - a-day drug regimen should be treated. Exclusion criteria 1- were examples of women during pregnancy and menstruation. 2 - Examples disease such as fever, leukemia, epilepsy, cellulitis and infection, deep vein thrombosis and psychosis and gastric cancer, thrombosis and was paralyzed. (Banned because of the reflections) 3 - Examples of problems in the leg were impaired and if the intervention was painful for them.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduce the number of acute vomiting in patients undergoing chemotherapy treatment method using Reflection. Timepoint: (first 4 hours -second 4 hours - third 4 hours) first 12 hours and second 12 hours after the intervention. Method of measurement: Questionnaire vomiting (a combination of questionnaires and the Moro National Cancer Institute Toxicity Criteria version 2 manual America).;Reduce the severity of acute vomiting in patients undergoing chemotherapy treatment method using Reflection. Timepoint: (first 4 hours -second 4 hours - third 4 hours) first 12 hours and second 12 hours after the interventionr the second. Method of measurement: Questionnaire vomiting (a combination of questionnaires and the Moro National Cancer Institute Toxicity Criteria version 2 manual America).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Yousefian Miandoab

University School of Nursing

n.yoosefian@yahoo.com+98 54 1322 6386

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026